Myomo Inc. Common Stock (MYO)
Frequently Asked Questions About Myomo Inc. Common Stock (MYO)
Does Myomo have partnerships with healthcare institutions?
Yes, Myomo has established partnerships with various healthcare institutions and rehabilitation centers. These collaborations are essential for facilitating clinical studies, integrating MyoPro devices into rehabilitation programs, and promoting awareness of the content and effectiveness of their solutions in improving patient outcomes.
How does Myomo approach research and development?
Myomo is committed to continuous research and development to innovate and enhance its product line. The company collaborates with leading academic institutions and engages in clinical trials to evaluate their technologies' effectiveness, which ensures that they remain at the forefront of medical advancements in rehabilitation.
How does Myomo ensure product quality?
Myomo ensures product quality through rigorous testing, adherence to regulatory standards, and continuous feedback from users and healthcare professionals. The company follows strict quality management systems and conducts regular evaluations throughout the production process to maintain high standards and deliver reliable devices.
How does Myomo Inc. fund its operations?
Myomo Inc. funds its operations through a combination of equity financing, product sales, grants, and collaborations with healthcare institutions. Like many startups in the medical technology field, the company has pursued investments to advance its research and development efforts.
Is Myomo Inc. publicly traded?
Yes, Myomo Inc. is publicly traded on the New York Stock Exchange under the ticker symbol MYO. The company became publicly listed in 2017, which has provided it with capital to further develop its innovative products and expand its market reach.
What are some key milestones in Myomo's history?
Key milestones in Myomo's history include the launch of the MyoPro device, achieving FDA clearance for its products, and becoming a publicly traded company. Furthermore, the company has formed significant partnerships with rehabilitation centers and healthcare providers to enhance patient delivery of their technologies.
What are the user experiences with Myomo products?
User experiences with Myomo products, particularly the MyoPro device, have generally been positive, with many users reporting significant improvements in their ability to perform daily activities and increased independence. Testimonials often highlight the device's ease of use and the positive impact it has on users' quality of life.
What challenges does Myomo face?
Myomo faces several challenges, including competition from other assistive technology providers, the need for ongoing regulatory approvals, and the financial constraints tied to the healthcare reimbursement landscape. Additionally, raising awareness and educating healthcare providers about the benefits of their technology is crucial for wider acceptance.
What does Myomo Inc. do?
Myomo Inc. specializes in developing and commercializing advanced robotic braces to help individuals with neuromuscular disorders regain mobility. Their primary product line includes devices that assist patients with limited arm and hand movement due to conditions such as stroke or spinal cord injury, enabling greater independence in daily tasks.
What is Myomo's growth strategy?
Myomo's growth strategy focuses on expanding its product offerings, enhancing market penetration in both existing and new territories, and fostering partnerships with healthcare providers. The company aims to establish its devices as a standard part of rehabilitation practices, thereby increasing adoption rates among healthcare professionals.
What is the competitive advantage of Myomo's products?
Myomo's competitive advantage lies in its unique technology that allows for intuitive control of robotic braces through the user’s muscle signals. This design not only improves user experience but also differentiates their products from other rehabilitation technologies that may not offer the same level of functionality or user engagement.
What is the financial outlook for Myomo Inc.?
The financial outlook for Myomo Inc. is shaped by its growth trajectory, market demand, and evolving healthcare landscape. As the company continues to enhance its product offerings and expand its market presence, analysts closely monitor its revenue growth, profit margins, and overall financial stability.
What is the MyoPro device?
The MyoPro device is a powered orthosis designed to help individuals with upper limb paralysis regain movement. It uses advanced sensing technology to respond to the user's muscle signals, providing the necessary assistance for tasks such as reaching, lifting, and holding objects, thereby improving the quality of life.
What is the vision of Myomo Inc.?
The vision of Myomo Inc. is to empower individuals with neuromuscular disorders to regain their independence and improve their quality of life through innovative technology. The company aims to be a leader in providing advanced solutions that enhance mobility, foster rehabilitation, and create better outcomes for patients worldwide.
What markets does Myomo operate in?
Myomo operates primarily within the medical technology market, specifically focusing on rehabilitation and assistive devices. In recent years, the company has expanded its presence in both domestic and international markets, aiming to reach patients in Europe, Asia, and beyond.
What role does Myomo play in rehabilitation?
Myomo plays a crucial role in rehabilitation by providing innovative solutions that enhance the effectiveness of therapy for individuals with mobility impairments. The company's devices are designed to be integrated into various rehabilitation protocols, offering users a means to actively participate in their recovery process while facilitating improved therapeutic outcomes.
When was Myomo Inc. founded?
Myomo Inc. was founded in 2004, initiated as a spin-off from research conducted at the Massachusetts Institute of Technology (MIT). Since its inception, the company has focused on creating innovative solutions to improve the lives of individuals with mobility impairments.
Where is Myomo Inc. headquartered?
Myomo Inc. is headquartered in Boston, Massachusetts. The location positions the company in a vibrant healthcare and technology ecosystem, allowing for close collaboration with academic institutions, medical professionals, and industry partners.
Who are the target customers for Myomo Inc.?
Myomo Inc. primarily targets individuals with upper extremity paralysis due to conditions such as stroke, brain injuries, or other neurological diseases. Their devices are also relevant for rehabilitation centers, hospitals, and healthcare professionals looking to enhance patient outcomes in mobility and functional independence.
What is the current price of Myomo Inc. Common Stock?
The current price of Myomo Inc. Common Stock is 4.350
When was Myomo Inc. Common Stock last traded?
The last trade of Myomo Inc. Common Stock was at 8:00 pm EDT on April 4th, 2025
What is the market capitalization of Myomo Inc. Common Stock?
The market capitalization of Myomo Inc. Common Stock is 91.02M
How many shares of Myomo Inc. Common Stock are outstanding?
Myomo Inc. Common Stock has 20.92M shares outstanding.